Key points
- Record revenue of $39.2m, up 16% from FY25
- Gross profit increased by 34% to $14.2m
- Operating costs reduced by 24% to $30.0m
- Achieved cash flow neutrality for FY26
- Secured significant commercial milestones
Full summary
Calix Limited (ASX: CXL) has reported its financial results for the year ended 30 June 2026. The company achieved record revenue of $39.2 million, a 16% increase from the previous year, and gross profit of $14.2 million, up 34%. Calix's Magnesia line of business contributed significantly to this growth, with revenue increasing by 40% to $34.0 million. Operating costs were reduced by 24% to $30.0 million, and cash capital expenditure was cut by 80% to $2.1 million. The company also secured several commercial milestones, including a new U.S. customer contract, a grant from the Australian Renewable Energy Agency, and a Joint Development Agreement with Rio Tinto. Calix expects to remain cash flow neutral in the 2026 calendar year.
Guidance
Calix expects to be cash flow neutral in the 2026 calendar year.
Outlook
Calix plans to continue growing revenue and gross profit in Magnesia, advance financing for the Zesty Demonstration Plant, and commercialize the Leilac technology through customer-funded projects.